Offering Strategic Operational Solutions
Menu
With over 25 years of experience in clinical research and drug development – including more than a decade in leadership roles – Stephanie brings deep expertise in study operations and delivery across a broad spectrum of pharma, biotech, and CRO environments.
Specializing in optimization of execution strategies for Oncology and Cell and Gene Therapy clinical trials, Stephanie is known for her ability to quickly assess opportunities & challenges and implement solutions. As a Fractional leader & Strategic Advisor, she provides high-level expertise to fast-track companies’ achievement of goals without the commitment of a full time hire.
Delays to market cost an average of $840.ooo per day in unrealized sales and continued clinical trial costs mapping to ~ $100 million dollars for a 5 month delay*
A seasoned Clinical Operations leader determines root cause, foresees risks and challenges ahead, implements mitigations and recenters the trial before delays occur.
In today’s uneven landscape, businesses need strategic leadership without long-term overhead and access to experts to maintain momentum.
Fractional leadership creates space for deep expertise, flexibility, and alignment in a way that traditional structures often can’t. It offers the ability to tap into seasoned professional insights, strategies, and results- exactly when you need them- without the commitment of a full-time hire.
Fractional support is ideal for:
My leadership style is practical and solutions-driven; focused on listening deeply, creating collaboration, designing strategy, driving operational efficiency, and delivering results.
Offering Strategic Operational Solutions
I partner with seed-stage companies seeking guidance on:
You’re not alone, and I’ve been where you are. I pinpoint the contributing challenges, design the strategy for solutions, and lead the execution.
I build governance frameworks and foster relationships to support you in a partnership for the long term. With a deep bench of CRO experience- I know the questions to ask, how to get the right-fit resources, available tools & metrics for oversight, and how to budget effectively to avoid surprises.
Operational due diligence provides a unique assessment of readiness to move from scientific strategy into clinical trials and beyond. I provide investor-ready trial feasibility, budgeting models, outsourcing strategies, risk mitigation strategies, and operational efficiency guidelines to support investment goals.
Before becoming a consultant, I served in senior-leadership roles in both Pharma and CRO, including Takeda, Syneos Health, and EMD Serono. I have worked in clinical operations for over 25 years and specialize in operationalizing novel and complex therapeutics including Cell and Gene Therapies. I have been instrumental in building strategies and governance structures that get results by looking outside the box to find solutions that work. My strong development skill set enables quick assessment of an organization’s opportunities and challenges and helps guide that organization to operational success.
